are glp 1 agonists safe Efficacy and Safety of Glucagon-Like Peptide-1 Receptor on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis GLP-1 Agonists For Obesity In
Description
The search for over-the-counter GLP-1 alternatives reflects growing interest in weight loss support
Compared with other second- or third-line glucose-lowering medications, the GLP-1RAs demonstrated a lower rate of adverse CVEs, including heart failure (HR 0.88
Type 2 diabetes represents a growing challenge for global public health
These findings underscore the potential for GLP-1 RAs to offer tailored protection against complex diabetic complications, marking an advancement in personalized medicine for managing diabetes-acute kidney disease.
